Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB02379 | Beta-D-Glucose | 2 | Recruiting | 1 |
DB00958 | Carboplatin | 2 | Recruiting | 1 |
DB00531 | Cyclophosphamide | 2 | Recruiting | 1 |
DB00773 | Etoposide | 2 | Recruiting | 1 |
DB01181 | Ifosfamide | 2 | Recruiting | 1 |
DB00480 | Lenalidomide | 2 | Recruiting | 1 |
DB15044 | Tafasitamab | 2 | Recruiting | 1 |